What clinicians should know about surrogate end points in hematologic malignancies
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Surrogate end points are frequently used in cancer clinical trials to predict treatment effectiveness early. This review clarifies their application and evaluation for researchers and clinicians.
Area Of Science
- Hematology/Oncology
- Clinical Trials
- Biostatistics
Background
- Surrogate end points are commonly used in hematology/oncology clinical trials.
- Unlike prognostic markers, surrogates predict the full treatment effect on true outcomes like overall survival.
- A clear understanding of surrogate end point validity is crucial for accurate research interpretation.
Purpose Of The Study
- To review the evidence supporting commonly used surrogate end points in hematology.
- To provide recommendations for the application and evaluation of surrogate end points in research and clinical practice.
- To bridge the gap between clinical practice and statistical expertise regarding surrogacy.
Main Methods
- Literature review of statistical and clinical trial methodologies.
- Analysis of the evidential level for common surrogate end points in hematology.
- Synthesis of recommendations for researchers and clinicians.
Main Results
- Discussion on the varying levels of evidence for different surrogate end points.
- Identification of best practices for surrogate end point selection and validation.
- Highlighting the importance of statistical rigor in surrogate end point research.
Conclusions
- Surrogate end points are valuable tools in clinical trials when appropriately validated.
- Clinicians and researchers should be aware of the evidence supporting specific surrogates.
- Adherence to methodological recommendations enhances the reliability of surrogate end point findings.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...